On this episode of Biotalk, Locust Walk‘s Geoff Meyerson welcomes Howard Federoff, Chief Medical Officer, Scientific Co-Founder and Director of Ryne Biotechnology, to the podcast. Join us as we delve into Ryne Bio’s pioneering work centered on advancing off-the-shelf neuron replacement therapies, poised to revolutionize the treatment landscape for neurological disorders. During the conversation, Howard shares his diverse background, drawing from his roles as a CEO overseeing companies employing both allo and auto-based approaches to cell therapy. He discusses the exciting prospects of a groundbreaking generation of cell therapy that eliminates the need for immunosuppression. Additionally, the episode explores the future of iPSC technology, which holds the promise of transforming the field, positioning it as the coveted “holy grail” in the realm of neurological treatment. We invite you to tune in to this engaging podcast episode. Subscribe or follow Biotalk on Apple Podcasts | 

0 Comments Sort By